Evidence map›Paper›PMID 32718409›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2020

Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy.

J L Kadota, A Katamba, A Musinguzi, F Welishe, J Nabunje, J L Ssemata, C A Berger, M R Kamya, J Namusobya, F C Semitala and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

J L KadotaDivision of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
A KatambaUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Department of Medicine, Makerere University, Kampala, Uganda.
A MusinguziInfectious Diseases Research Collaboration, Kampala, Uganda.
F WelisheInfectious Diseases Research Collaboration, Kampala, Uganda.
J NabunjeInfectious Diseases Research Collaboration, Kampala, Uganda.
J L SsemataInfectious Diseases Research Collaboration, Kampala, Uganda.
C A BergerDivision of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
M R KamyaDepartment of Medicine, Makerere University, Kampala, Uganda, Infectious Diseases Research Collaboration, Kampala, Uganda.
J NamusobyaUniversity Research Company, Center for Human Services, Department of Defense HIV/AIDS Prevention Program (URC-DHAPP), Kampala, Uganda.
F C SemitalaDepartment of Medicine, Makerere University, Kampala, Uganda, Infectious Diseases Research Collaboration, Kampala, Uganda, Makerere University Joint AIDS Program, Kampala, Uganda.
A CattamanchiDivision of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
D W DowdyUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, <email></email>, Email: axk95@case.edu.

Funding

Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trialR01HL138728 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI David Wesley Dowdy, Emily A Kendall · 2017 to 2026
$5.4M
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options TrialR01HL144406 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adithya Cattamanchi, David Wesley Dowdy · 2018 to 2026
$4.4M
NHLBI NIH HHS R01 HL138728NHLBI NIH HHS R01 HL144406
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsTuberculosisAmbulatory Care FacilitiesHumansRisk Factors

Identifiers

PMID32718409
PMCPMC7891860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.